CRL executive reports stock gifts and holdings

Charles River Laboratories executive Shannon M. Parisotto, Chief Executive Vice President for Discovery & Safety Assessment, reported non-market movements in Common Stock.

Rhea-AI Filing Summary

Charles River Laboratories executive Shannon M. Parisotto, Chief Executive Vice President for Discovery & Safety Assessment, reported non-market movements in Common Stock. On June 5, 2026, she made bona fide gifts totaling 3,058 shares, with 1,529 shares transferred as an exempt move under Rule 16a-13 to a revocable trust she controls.

After these transactions, she holds 9,853 Common Stock shares directly, 9,680 shares indirectly through a trust, and 28,510 shares indirectly via Karpathos Investments LLC. All reported actions are gifts or internal reallocations, not open-market purchases or sales.

Insights

Insider transactions analyst

Form 4 shows routine gifts and internal share transfers, not market trades.

The filing reports that executive Shannon M. Parisotto made bona fide gifts of 3,058 Common Stock shares on June 5, 2026. One 1,529-share movement is explicitly described as an exempt transfer under Rule 16a-13 to a revocable trust she controls, indicating an internal reallocation of ownership.

No open-market buys or sells occurred, and there are no derivative exercises. After these actions she still holds 9,853 shares directly, 9,680 via a trust, and 28,510 via Karpathos Investments LLC, so the reported gifts represent a modest portion of her visible equity exposure.

Insider Trade Summary

3,058 shares gifted

Gift 3 txns

Insider Parisotto Shannon M

Role CEVP, Disc & Safety Assessment

Type	Security	Shares	Price	Value
Gift	Common Stock	1,529	$0.00	$0.00
Gift	Common Stock	1,529	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 9,853 shares (Direct); Common Stock — 9,680 shares (Indirect, By Trust); Common Stock — 28,510 shares (Indirect, by Karpathos Investments LLC)

Footnotes (1)

1. F1. Reflects the exempt transfer pursuant to Rule 16a-13 of 1,529 shares held by the reporting person to a revocable trust controlled by the reporting person.

Key Figures

Gifted shares per transaction: 1,529 shares Total gifted shares: 3,058 shares Direct holdings after transactions: 9,853 shares +2 more

5 metrics

Gifted shares per transaction 1,529 shares Bona fide gift of Common Stock on June 5, 2026

Total gifted shares 3,058 shares Sum of two bona fide gift transactions on June 5, 2026

Direct holdings after transactions 9,853 shares Common Stock held directly following June 5, 2026 gifts

Indirect trust holdings after transactions 9,680 shares Common Stock held indirectly "By Trust" after June 5, 2026

Indirect LLC holdings 28,510 shares Common Stock held indirectly by Karpathos Investments LLC

Key Terms

bona fide gift, Rule 16a-13, revocable trust, indirect ownership, +1 more

5 terms

bona fide gift financial

"transaction_code_description": "Bona fide gift""

A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.

Rule 16a-13 regulatory

"Reflects the exempt transfer pursuant to Rule 16a-13 of 1,529 shares"

revocable trust financial

"to a revocable trust controlled by the reporting person"

A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.

indirect ownership financial

""ownership_type": "indirect""

Common Stock financial

""security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did CRL executive Shannon M. Parisotto report in this Form 4?

Shannon M. Parisotto reported bona fide gifts totaling 3,058 shares of Charles River Laboratories Common Stock on June 5, 2026. These are non-market transfers, including an exempt reallocation to a revocable trust she controls under Rule 16a-13.

How many Charles River Laboratories (CRL) shares did the executive gift?

She gifted a total of 3,058 Common Stock shares, split into two 1,529-share bona fide gift transactions on June 5, 2026. One 1,529-share movement is described as an exempt transfer to a revocable trust that she controls.

Were there any open-market stock sales or purchases by the CRL executive?

No open-market sales or purchases are reported. The Form 4 only shows bona fide gifts and an exempt transfer under Rule 16a-13. All movements are non-cash, non-market transactions rather than discretionary trades in the public market.

What are Shannon M. Parisotto’s Charles River Laboratories share holdings after the transactions?

After the reported gifts, she holds 9,853 Common Stock shares directly, 9,680 shares indirectly through a trust, and 28,510 shares indirectly via Karpathos Investments LLC. These figures reflect her visible ownership as of the Form 4’s transaction date.

What does the Rule 16a-13 exempt transfer mean in this CRL Form 4?

The filing notes an exempt transfer under Rule 16a-13 of 1,529 shares from the reporting person to a revocable trust she controls. This indicates an internal shift in how shares are held, not a sale or purchase in the market.

How are indirect holdings reported for the CRL executive in this Form 4?

Indirect holdings are shown as 28,510 shares held by Karpathos Investments LLC and 9,680 shares held "By Trust." These entries indicate ownership through related entities rather than directly in her own name.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/08/2026 - 04:19 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Parisotto Shannon M

(Last) (First) (Middle)

C/O CHARLES RIVER LABORATORIES

251 BALLARDVALE STREET

(Street)

WILMINGTON MASSACHUSETTS 01887

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. [ CRL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEVP, Disc & Safety Assessment

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/05/2026		G		1,529(1)	D	$0	9,853	D
Common Stock	06/05/2026		G		1,529(1)	A	$0	9,680	I	By Trust
Common Stock								28,510	I	by Karpathos Investments LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the exempt transfer pursuant to Rule 16a-13 of 1,529 shares held by the reporting person to a revocable trust controlled by the reporting person.

	/s/ Shannon M. Parisotto	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)